Delivery Order SPE2DB22D1106-SPE2DB24FFLW1
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication for the treatment of diabetes. The contract has a ceiling value of $1,535.66 and a period of performance ending on April 17, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a delivery order contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication, with a ceiling value of $1,022.80 and a period of performance through January 28, 2025. The contract is a firm-fixed-price, non-set-aside award. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $2,580.38 firm fixed price contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The contract has a completion date of September 9, 2024 and is not associated with any set-aside program. Amerisourcebergen is a significant federal contractor, holding Indefinite Delivery Contracts (IDCs) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication product. The contract has a ceiling value of $3,177.72 and is a firm fixed-price delivery order with a period of performance through March 6, 2023. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have a set-aside designation, indicating open...
- This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The award has a fixed-price delivery order contract type, with a ceiling value of $3,193.14 and a period of performance through September 11, 2024. The contract is not set aside for any specific business type. As a large pharmaceutical distributor,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,187.60, is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The contract has a firm fixed price pricing type and a completion date of May 16, 2024. There is no set-aside designation for this award. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a firm fixed price delivery order contract (SPE2DX15D3015|SPE2DX24F0GR0) by the Defense Logistics Agency (DLA) Troop Support Medical to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The award has a ceiling value of $2,495.23 and a period of performance through March 25, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a ceiling value of $1,013.89 and a performance period through April 5, 2024. This delivery order is placed under a larger indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication. The contract has a ceiling value of $17,365.18 and a period of performance through October 18, 2023. The contract is a firm-fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.64, is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. The contract has a period of performance through March 3, 2025 and is structured as a firm fixed-price arrangement. No set-aside designation was used for this award. AmerisourceBergen holds a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FFLW1Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has a ceiling value of $3,364.74 and a period of performance through September 10, 2024. This award is not associated with any set-aside program. Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies, primarily for the supply of essential pharmaceutical products and medical supplies to support government healthcare programs and military treatment facilities nationwide. The company holds several high-value Indefinite Delivery Contracts (IDCs) with agencies like the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, to efficiently provide a comprehensive range of medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/9/24 |